Frazier Healthcare Partners has acquired a 50% stake in CSafe Global from Thomas H. Lee Partners (THL), according to a news release.
CSafe Global, based in Dayton, Ohio, is a provider of cold chain shipping solutions to global … Continue Reading
Category Archives: Life Sciences Investing
Subscribe to Life Sciences Investing RSS FeedBlackstone Closes Life Sciences Fund With $4.6 Billion
Posted in Life Sciences InvestingBlackstone has announced the closing of its inaugural life sciences fund with $4.6 billion of total capital commitments.
The company stated that the fund, Blackstone Life Sciences V, is the largest life sciences private fund raised to date.
Blackstone Life … Continue Reading
GTCR Portfolio Company Maravai LifeSciences Acquires MockV Solutions
Posted in Life Sciences InvestingMaravai LifeSciences, a portfolio company of GTCR, has announced it has acquired MockV Solutions.
Maravai, based in San Diego, is a provider of life science reagents and services to researchers and biotech partners. The company focuses on DNA and … Continue Reading
Blackstone Forms Life Sciences Investment Platform With Closing of Clarus Acquisition
Posted in Life Sciences Investing, UncategorizedThe Blackstone Group has announced the closing of its acquisition of Clarus. The business will now operate as Blackstone Life Sciences.
Blackstone indicated that its new private investment platform will invest across the lifecycle of companies and products within life … Continue Reading
Healthcare & Life Sciences Private Equity Deal Tracker: Avista to Acquire Miraca Life Sciences
Posted in Life Sciences InvestingAvista Capital Partners will acquire Miraca Life Sciences from Miraca Holdings, according to a news release.
Miraca Life Sciences, based in Irving, Texas, is a national, independent anatomic pathology lab providing subspecialty anatomic pathology services in the fields … Continue Reading
Signet Closes Fourth Life Science Fund at $137 Million
Posted in Life Sciences InvestingSignet Healthcare Partners has announced it has closed its fourth life science fund, Signet Healthcare Partners IV L.P., with $137.2 million of capital commitments.
Signet, based in New York and founded in 1998, is a private equity fund that … Continue Reading
Healthcare & Life Sciences Private Equity Deal Tracker: Warburg Pincus to Acquire Stake in Hygenia
Posted in Life Sciences InvestingWarburg Pincus has announced it will invest in Hygenia.
Warburg Pincus, headquartered in New York, is a PE firm that takes a long-term perspective and invest in businesses at all stages of development. It invests healthcare and several other … Continue Reading
Healthcare & Life Sciences Private Equity Deal Tracker: Precision BioSciences Secures $25.6 Million in Financing
Posted in Life Sciences InvestingPrecision BioSciences has announced it has secured $25.6 million in series A financing.
Precision BioSciences is a Durham, N.C.-based genome editing company. Its ARCUS genome editing technology is designed to produce nucleases that can insert, remove and modify DNA in … Continue Reading
Healthcare & Life Sciences Private Equity Deal Tracker: Andrew Alliance Secures Series B Financing
Posted in Life Sciences InvestingAndrew Alliance has announced the closing of a series B financing round.
Andrew Alliance, which is based in Switzerland and will be opening an office in Boston, is a developer of life science robotics. In January 2013, Andrew Alliance … Continue Reading
Healthcare & Life Sciences Private Equity Deal Tracker: iRhythm Technologies Secures $17 Million in Financing
Posted in Life Sciences InvestingiRhythm Technologies has announced it completed raising $17 million in series E financing.
iRhythm, headquartered in San Francisco, is a privately held healthcare information services company that focuses on the management of cardiac arrhythmia information.
The financing round was … Continue Reading
Healthcare & Life Sciences Private Equity Deal Tracker: Adaptive Biotechnologies Secures $105 Million in Financing
Posted in Life Sciences InvestingAdaptive Biotechnologies has announced it has completed a series C financing round and completed a newly created series D round of financing with a $105 million investment from Viking Global Investors.
Adaptive Biotechnologies, based in Seattle, Wash., is an … Continue Reading
Clarus Ventures Seeks to Raise $375 Million for New Life Sciences VC Fund
Posted in Life Sciences InvestingClarus Ventures has set out to raise $375 million for a new life sciences VC fund, according to multiple reports, including a San Francisco Business Times report.
Clarus Ventures is a healthcare VC firm with offices in Cambridge, Mass., … Continue Reading
Healthcare & Life Sciences Private Equity Deal Tracker: Akebia Therapeutics Raises $41 Million in Series C Financing
Posted in Life Sciences InvestingAkebia Therapeutics has announced (pdf) it has completed a $41 million Series C financing.
Akebia Therapeutics, headquartered in Cincinnati, is a biopharmaceutical company focused on the development of small molecules for the treatment of anemia and vascular disease.
Satter … Continue Reading
Healthcare & Life Sciences Private Equity Deal Tracker: Radius Health Raises $43 Million in New VC Funding
Posted in Life Sciences InvestingRadius Health, Inc., has announced it has completed a new equity financing of $43 million.
Radius, based in a Cambridge, Mass., is a biopharmaceutical company focused on developing new therapeutics for the treatment of osteoporosis and other women’s health … Continue Reading
Private Equity Investing in the Compounding Pharmacy Sector
Posted in Life Sciences InvestingIn light of the integrity and clinical issues raised by the New England Compounding Centers far-reaching recalls in late 2012, the FDA has urged officials from all 50 states to close regulatory loopholes involving the safety of compounding drugs for … Continue Reading
Healthcare & Life Sciences Private Equity Deal Tracker: Versartis Raises $25 Million in Series C Financing Led by Aisling Capital
Posted in Life Sciences InvestingVersartis, Inc. has announced it has raised $25 million in series C financing led by Aisling Capital.
Versartis, headquartered in Redwood City, Calif., is a biotechnology company developing therapeutics for patients with endocrine disorders.
Aisling Capital, headquartered in … Continue Reading
Agencies Have Conflicting Interpretations re Taxable Medical Devices
Posted in Life Sciences InvestingReferencing S. O’Shea, R. Ricchio’s Law360 article “Mixing Agency Rules May Mean More Taxable Medical Devices" , our McGuireWoods colleagues Melissa Gilmore and Mary DeBartolo recently queried which medical devices are taxable and noted conflicting agency interpretations.
As our colleagues note, … Continue Reading
McGuireWoods Attorneys Discuss US Supreme Court Healthcare Reform Decision
Posted in Healthcare Services Investing, Industry Events and Announcements, Life Sciences InvestingJust minutes and hours after the US Supreme Court issued its much-anticipated decision regarding the constitutionality of The Patient Protection and Affordable Care Act (PPACA or ACA) on June 28th, commentators in all walks of life scrambled to offer their insights … Continue Reading
ACOs Working Out Initial Difficulties
Posted in Life Sciences InvestingApparently some early participants in the accountable care organization (ACO) program are experiencing problems accessing crucial CMS (Centers for Medicare and Medicaid Services) data.
The acting administrator of CMS has reported to ACO supervisors and others at a conference last … Continue Reading
U.S. Supreme Court Begins Much-Anticipated Oral Arguments re Healthcare Reform
Posted in Healthcare Services Investing, Life Sciences InvestingIt is virtually impossible to turn on a TV, radio or podcast . . . or pick up a newspaper or peruse the internet . . . without hearing that the U.S. Supreme Court today began three days of potentially … Continue Reading
Orphan Disease Therapy Investments
Posted in Life Sciences InvestingPerhaps despite not having the cache of ‘guaranteed-weight-loss’, ‘quit smoking now’ or even a cure-all for cancer, pharmaceuticals for the treatment of rare diseases can be an attractive investment strategy.
Amicus Therapeutics is the developer of small molecule, orally administered … Continue Reading
Sony Makes Inroads into Health-Care in a Big Way
Posted in Life Sciences InvestingPut aside your Sony flat-screen TVs and Blu-Ray players and make way for —flow cytometry. Why is Sony Corporation, a proven global manufacturer in the field of audio, video game, communications, key device and information technology, venturing in the turbulent, … Continue Reading
A Decade of Private Equity Investments
Posted in Healthcare Services Investing, Life Sciences InvestingPitchbook has reported on a decade of private equity investments in a four-part series focusing on investments, fundraising, exits and fund returns. The highlights are illuminating of the period from 2001 through 2010, with the unsurprising peak in 2007 and … Continue Reading
Diagnostic & Monitoring Device Companies Attractive Investment
Posted in Life Sciences InvestingSince the beginning of 2011, medical diagnostic and monitoring device companies have been performing in an established and even an exceptional manner. To date, these specialized medical device businesses have shown double-digit EPS growth and organic revenue growth in the … Continue Reading